Clinical trial
Fecal Microbiota Transplant (FMT) After Treatment for a First Episode of Clostridium Difficile Infection (CDI)
NCT03795233 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fecal Microbiota Transplant (FMT) After Treatment for a First Episode of Clostridium Difficile Infection (CDI)
- Lead sponsor
- Boston Medical Center
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- August 23, 2019
- Completion date
- January 15, 2021
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clostridium difficile infection